ZyVersa Therapeutics’ CEO, Stephen C. Glover, and CCO, Karen A. Cashmere, Are Invited Speakers at the 4th Inflammasome Therapeutics Summit
- Tuesday, November 22, 2022, 7:12
- Business
- Add a comment
Annual Inflammasome Summit unites world renowned experts in inflammasome-targeted drug development and academia to share information and address knowledge gaps in this rapidly evolving field ZyVersa is well positioned in the emerging inflammasome space with a highly differentiated…
About the Author
adminasapcorp has written 39584 stories on this site.